Sarah Ali, MD, is a medical oncologist and hematologist practicing in Indianapolis and Mooresville, Indiana. Her clinical interest is in the treatment of breast cancer and hematologic malignancies. Dr. Ali completed her residency training at McLaren Regional Medical Center, Michigan State University College of Human Medicine in Flint, Michigan and obtained her fellowship in hematology and oncology at Michigan State University.
Ahad Sadiq, MD, is board certified in internal medicine, hematology, and oncology, and has a special interest in thoracic oncology. He leads several clinical trials in thoracic oncology at Fort Wayne Medical Oncology and Hematology—focusing on the benefit of using immunotherapies.
John Edwards, MD, is a pediatric hematologist-oncologist in Indianapolis, Indiana. He received his medical degree from University of Florida College of Medicine and has been in practice for more than 20 years.
Mark A. Henderson, MD, trained at Indiana University School of Medicine in radiation oncology and taught there for six years. He later moved to Oregon where he worked for a private practice and taught at Oregon Health and Science University. In 2018, Dr. Henderson returned to Indiana to be closer to family and to work for the Columbus Regional Health Cancer Center.
Dr. Henderson is skilled in gamma knife and linear accelerator-based radiosurgery, stereotactic body radiotherapy, intensity-modulated radiotherapy, image-guided radiotherapy, 3D-conformal radiotherapy, partial breast brachytherapy and unsealed source radiotherapy. He is board certified in radiation oncology by the American Board of Radiology.
Amikar Sehdev, MD, MPH, is board certified in internal medicine and medical oncology. Dr. Sehdev received his medical degree from the Government Medical College and Hospital, Chandigarh in India. He completed his internal medicine residency at John H. Stroger, Jr. Hospital of Cook County in Chicago and his hematology/oncology fellowship at the University of Chicago.
Dr. Sehdev has completed American Association for Cancer Research fellowships in methods in clinical cancer research and integrative molecular epidemiology.